We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

COP:NYSEConocoPhillips Analysis

Data as of 2026-03-09 - not real-time

$117.03

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

ConocoPhillips is trading at $117.03, comfortably above its 20‑day SMA (112.45) and 50‑day SMA (104.14), with the 20‑day SMA still above the 200‑day SMA (94.99), signaling a sustained bullish trend. Momentum indicators reinforce this view: the RSI sits at 66.7, the MACD line (3.75) is above its signal (3.61) and the histogram is positive, while volume is on an increasing trend. Valuation metrics are mixed – the forward P/E of 17.2 is modestly below the industry average of 20.6, yet the market price is far above the DCF‑derived fair value of $70.4, implying a potential overvaluation of roughly 50% upside/downside. The company delivers a 2.87% dividend yield with a 50% payout ratio, supported by strong operating cash flow ($19.8 B) and free cash flow ($7.5 B). Recent analyst activity is divergent: UBS upgraded its price target to $144 and reaffirmed a Buy rating, while Roth Capital trimmed its outlook to Neutral. Geopolitical headlines, such as the recent U.S. actions in Iran, have lifted oil sentiment, pushing the sector to new 52‑week highs.
Fundamentally, COP posts a solid gross margin of 46% and an operating margin of 16%, with ROE at 12.4% and a debt‑to‑equity ratio of 37.8, indicating manageable leverage. The balance sheet holds $6.98 B in cash against $24.4 B of debt, and the beta near 1 suggests market‑aligned volatility, complemented by a 30‑day volatility of 27.5%. While the energy sector faces medium regulatory risk from climate policies, COP’s diversified global footprint—including LNG and unconventional assets—mitigates geographic concentration. Overall, the stock presents a bullish technical setup, attractive dividend income, and upside potential from analyst upgrades, tempered by valuation concerns and sector‑specific risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (SMA alignment, MACD, rising volume)
  • Mixed analyst sentiment (UBS upgrade vs. Roth downgrade)
  • Elevated valuation relative to DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Upside catalyst from UBS target of $144
  • Strong cash generation and sustainable dividend
  • Industry‑average earnings multiples offering relative value

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Diversified global asset base reducing geographic risk
  • Consistent dividend yield supporting total return
  • Long‑term demand for oil and LNG despite transition pressures

Key Metrics & Analysis

Financial Health

Revenue Growth-6.80%
Profit Margin13.25%
P/E Ratio18.4
ROE12.36%
ROA6.42%
Debt/Equity37.83
P/B Ratio2.2
Op. Cash Flow$19.8B
Free Cash Flow$7.5B
Industry P/E20.6

Technical Analysis

TrendBullish
RSI66.7
Support$107.06
Resistance$122.50
MA 20$112.45
MA 50$104.14
MA 200$95.00
MACDBullish
VolumeIncreasing
Fear & Greed Index75.89

Valuation

Fair Value$70.42
Target Price$117.63
Upside/Downside0.51%
GradeOvervalued
TypeBlend
Dividend Yield2.87%

Risk Assessment

Beta0.99
Volatility27.55%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.